Risk Factors and Frequency of Foot Ulceration in Patients Receiving Chronic Hemodialysis Treatment

Adv Skin Wound Care. 2024 Apr 1;37(4):203-210. doi: 10.1097/ASW.0000000000000117.

Abstract

Objective: To determine the prevalence and risk factors of foot ulceration in patients receiving hemodialysis treatment.

Methods: A total of 180 patients who received hemodialysis treatment in two state hospitals and a private health center between April 2017 and September 2017 were included in the study. The researchers collected data using a patient information form and by conducting physical evaluation of the lower extremities. They used the diabetic foot risk assessment algorithm to classify risk according to the data obtained.

Results: Of the patients receiving hemodialysis treatment, 6.7% had foot ulceration, 19.4% had a history of foot ulceration, and 8.3% had a history of hospitalization associated with ulceration in a lower extremity. Infected foot ulceration was the most common (6.1%) cause of hospitalizations. In the group with current or past foot ulceration, diabetic nephropathy was the most common etiologic factor of end-stage kidney disease (48.6%); there was a significant between-group difference in diabetic nephropathy (P < .05). Etiologic factors had a significant effect on foot ulcerations: As determined by univariate logistic regression, diabetes (odds ratio [OR], 2.727; P < .05), presence of neuropathy (OR, 4.208; P < .05), low-density lipoprotein cholesterol (OR, 1.013; P < .05), and serum albumin (OR, 0.302; P < .036) all had a statistically significant effect on the presence of foot ulcerations.

Conclusions: Patients receiving hemodialysis treatment are at high risk for foot ulceration. Therefore, patient awareness strategies should be expanded to include individuals with end-stage renal disease regardless of diabetes status. Clinical and dialysis nurses should educate these patients about foot ulcerations and foot health to prevent ulcer development.

MeSH terms

  • Algorithms
  • Diabetic Nephropathies* / epidemiology
  • Diabetic Nephropathies* / therapy
  • Humans
  • Kidney Failure, Chronic* / therapy
  • Renal Dialysis / adverse effects
  • Risk Factors